These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 795370)

  • 21. Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.
    Siebert WT; Moreland N; Williams TW
    J Infect Dis; 1979 Apr; 139(4):452-7. PubMed ID: 438546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial kinetics of drug action against gram-positive and gram-negative organisms. III: Effect of lincomycin and clindamycin combinations on Staphylococcus aureus and Escherichia coli.
    Heman-Ackah SM
    J Pharm Sci; 1975 Oct; 64(10):1621-6. PubMed ID: 1102659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bactericidal effect of combinations of antimicrobial drugs and antineoplastic antibiotics against Staphylococcus aureus.
    Jacobs JY; Michel J; Sacks T
    Antimicrob Agents Chemother; 1979 Apr; 15(4):580-6. PubMed ID: 464589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The in vitro effect of a combination of sulbactam with cephalothin and cefazolin on strains of Escherichia coli and Proteus mirabilis which produce beta lactamase].
    Múcková M; Milosovic P
    Bratisl Lek Listy; 1990 Apr; 91(4):303-8. PubMed ID: 2198081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
    Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of subinhibitory concentrations of penicillin, cephalothin, and clindamycin on Staphylococcus aureus growth in human phagocytic cells.
    Elliott GR; Peterson PK; Verbrugh HA; Freiberg MR; Hoidal JR; Quie PG
    Antimicrob Agents Chemother; 1982 Nov; 22(5):781-4. PubMed ID: 7181488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of penicillinase-forming strains of Staphylococcus aureus and of their penicillinase-negative variants to cephaloridine, cephalothin, methicillin, and benzylpenicillin.
    Hewitt JH; Parker MT
    J Clin Pathol; 1968 Jan; 21(1):75-84. PubMed ID: 5188489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of different factors on the production of L-phase variants in individual E. coli strains.
    Seeberg S; Brorson JE
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Apr; 82(2):214-8. PubMed ID: 4604603
    [No Abstract]   [Full Text] [Related]  

  • 29. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bacteriostatic action of penicillin on Escherichia coli K12].
    Levashev VS; Sivov IG
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):24-6. PubMed ID: 6342308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The of effect of rolitetracycline on oxygen consumption in a suspension of E. coli].
    Hirsch M; Vejbora O
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1990; 33(5):721-9. PubMed ID: 2130506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1499-504. PubMed ID: 7492093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics and mechanisms of drug action on microorganisms. XVII. Bactericidal effects of penicillin, kanamycin, and rifampin with and without organism pretreatment with bacteriostatic chloramphenicol, tetracycline, and novobiocin.
    Garrett ER; Won CM
    J Pharm Sci; 1973 Oct; 62(10):1666-73. PubMed ID: 4584653
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibiotic efficacy is linked to bacterial cellular respiration.
    Lobritz MA; Belenky P; Porter CB; Gutierrez A; Yang JH; Schwarz EG; Dwyer DJ; Khalil AS; Collins JJ
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8173-80. PubMed ID: 26100898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibilities of four species of coagulase-negative staphylococci.
    Fass RJ; Helsel VL; Barnishan J; Ayers LW
    Antimicrob Agents Chemother; 1986 Oct; 30(4):545-52. PubMed ID: 3539009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of bovine lactoferrin hydrolysate on the in vitro antimicrobial susceptibility of Escherichia coli strains isolated from baby pigs.
    Chen PW; Ho SP; Shyu CL; Mao FC
    Am J Vet Res; 2004 Feb; 65(2):131-7. PubMed ID: 14974567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the drug resistance of Staphylococci and Escherichia coli against antibiotics. II. General tendency of resistant strains.
    Otaya H; Okamoto S; Inoue E; Adachi Y; Machihara S; Yoshimura M
    J Antibiot (Tokyo); 1970 Jul; 23(7):324-35. PubMed ID: 4918327
    [No Abstract]   [Full Text] [Related]  

  • 38. [Rifampicin: a bacteriostatic and bactericidal agent].
    Baudens JG; Chabbert YA
    Pathol Biol (Paris); 1969 Apr; 17(7):392-7. PubMed ID: 4307548
    [No Abstract]   [Full Text] [Related]  

  • 39. Paradoxical action of penicillin G on Staphylococcus aureus: a time study of the effect of a zonal antibiotic concentration gradient on bacterial growth.
    Yourassowsky E; Vanderlinden MP; Lismont MJ; Schoutens E
    Antimicrob Agents Chemother; 1975 Sep; 8(3):262-5. PubMed ID: 1167041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promethazine renders Escherichia coli susceptible to penicillin G: real-time measurement of bacterial susceptibility by fluoro-luminometry.
    Lehtinen J; Lilius EM
    Int J Antimicrob Agents; 2007 Jul; 30(1):44-51. PubMed ID: 17475447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.